Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evidence for an Increase in Cannabis Use in Iran – a Systematic Review and Trend Analysis Publisher Pubmed



Rostamabadi Y1 ; Gholami J1 ; Aminesmaeili M1, 2 ; Baheshmat S1, 3 ; Hamzehzadeh M1, 3 ; Rafiemanesh H4 ; Nasserbakht M5 ; Ghalichi L6 ; Safarcherati A1 ; Taremian F7 ; Mojtabai R2 ; Rahimimovaghar A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Mental Health Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
  3. 3. Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Student Research Committee, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Mental Health Research Center, Tehran Psychiatry Institute, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Mental Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Science, Tehran, Iran
  7. 7. Substance Abuse and Dependence research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Source: PLoS ONE Published:2021


Abstract

Background and aims Cannabis is the most widely used illicit substance globally. In this systematic review, we examined the prevalence and trends of cannabis use and cannabis use disorder in Iran. Methods We searched International and Iranian databases up to March 2021. Pooled prevalence of use among sex subgroups of the general population, university and high school students, combined youth groups, and high-risk groups was estimated through random-effects model. Trends of various use indicators and national seizures were examined. Results Ninety studies were included. The prevalence estimates of last 12-month cannabis use were 1.3% (95%CI: 0.1–3.6) and 0.2% (95%CI: 0.1–0.3) among the male and female Iranian general population, respectively. The prevalence of cannabis use disorder among general population in national studies rose from 0% in 2001 to 0.5% in 2011. In the 2016–2020 period, the pooled prevalence estimates of last 12-month cannabis use were 4.9% (95% CI: 3.4–6.7) and 0.3% (95% CI: 0.0–1.3) among males and females of “combined youth groups”, respectively. The linear trend of last 12-month cannabis use among males of combined youth groups and among female university students increased significantly from 2000 to 2020. Conclusions Prevalence of cannabis use in Iran is low compared to many countries. However, there is strong evidence of an increase in cannabis use among the youth and some evidence for an increase in cannabis use disorder. Copyright: © 2021 Rostam-Abadi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Other Related Docs
10. Extension of the Theory of Planned Behavior (Tpb) to Predict Patterns of Marijuana Use Among Young Iranian Adults, International Journal of Environmental Research and Public Health (2020)
12. Frequency of Tobacco Use Among Students in Tehran City, Tehran University Medical Journal (2015)
15. Six-Year Follow-Up of People Who Use Methamphetamine in Iran: A Case Series Study, International Journal of High Risk Behaviors and Addiction (2023)
18. Substance Use and Its Related Factors Among Iranian University Students., Pakistan Journal of Medical and Health Sciences (2021)
20. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
38. Substance Use Among Poisoned Teenage Patients, Iranian Journal of Public Health (2019)
41. Epidemiology of Hiv in Iran, Current HIV Research (2020)
47. Cognitive Impairment in Opium Use Disorder, Behavioural Neurology (2021)